84 related articles for article (PubMed ID: 8615045)
1. Mutational analysis of the fusion peptide of the human immunodeficiency virus type 1: identification of critical glycine residues.
Delahunty MD; Rhee I; Freed EO; Bonifacino JS
Virology; 1996 Apr; 218(1):94-102. PubMed ID: 8615045
[TBL] [Abstract][Full Text] [Related]
2. Effect of nonpolar substitutions of the conserved Phe11 in the fusion peptide of HIV-1 gp41 on its function, structure, and organization in membranes.
Pritsker M; Rucker J; Hoffman TL; Doms RW; Shai Y
Biochemistry; 1999 Aug; 38(35):11359-71. PubMed ID: 10471286
[TBL] [Abstract][Full Text] [Related]
3. Mutations of conserved glycine residues within the membrane-spanning domain of human immunodeficiency virus type 1 gp41 can inhibit membrane fusion and incorporation of Env onto virions.
Miyauchi K; Curran R; Matthews E; Komano J; Hoshino T; Engelman DM; Matsuda Z
Jpn J Infect Dis; 2006 Apr; 59(2):77-84. PubMed ID: 16632906
[TBL] [Abstract][Full Text] [Related]
4. Functional analysis of the disulfide-bonded loop/chain reversal region of human immunodeficiency virus type 1 gp41 reveals a critical role in gp120-gp41 association.
Maerz AL; Drummer HE; Wilson KA; Poumbourios P
J Virol; 2001 Jul; 75(14):6635-44. PubMed ID: 11413331
[TBL] [Abstract][Full Text] [Related]
5. Role of the fusion peptide and membrane-proximal domain in HIV-1 envelope glycoprotein-mediated membrane fusion.
Dimitrov AS; Rawat SS; Jiang S; Blumenthal R
Biochemistry; 2003 Dec; 42(48):14150-8. PubMed ID: 14640682
[TBL] [Abstract][Full Text] [Related]
6. Anti-HIV activity of multibranched peptide constructs derived either from the cleavage sequence or from the transmembrane domain (gp41) of the human immunodeficiency virus type 1 envelope.
Sabatier JM; Mabrouk K; Moulard M; Rochat H; Van Rietschoten J; Fenouillet E
Virology; 1996 Sep; 223(2):406-8. PubMed ID: 8806580
[TBL] [Abstract][Full Text] [Related]
7. Conserved residues in the coiled-coil pocket of human immunodeficiency virus type 1 gp41 are essential for viral replication and interhelical interaction.
Mo H; Konstantinidis AK; Stewart KD; Dekhtyar T; Ng T; Swift K; Matayoshi ED; Kati W; Kohlbrenner W; Molla A
Virology; 2004 Nov; 329(2):319-27. PubMed ID: 15518811
[TBL] [Abstract][Full Text] [Related]
8. Role of the specific amino acid sequence of the membrane-spanning domain of human immunodeficiency virus type 1 in membrane fusion.
Miyauchi K; Komano J; Yokomaku Y; Sugiura W; Yamamoto N; Matsuda Z
J Virol; 2005 Apr; 79(8):4720-9. PubMed ID: 15795258
[TBL] [Abstract][Full Text] [Related]
9. The stability of the intact envelope glycoproteins is a major determinant of sensitivity of HIV/SIV to peptidic fusion inhibitors.
Gallo SA; Sackett K; Rawat SS; Shai Y; Blumenthal R
J Mol Biol; 2004 Jun; 340(1):9-14. PubMed ID: 15184018
[TBL] [Abstract][Full Text] [Related]
10. Determinants of membrane activity from mutational analysis of the HIV fusion peptide.
Torres O; Bong D
Biochemistry; 2011 Jun; 50(23):5195-207. PubMed ID: 21561063
[TBL] [Abstract][Full Text] [Related]
11. Role of envelope processing and gp41 membrane spanning domain in the formation of human immunodeficiency virus type 1 (HIV-1) fusion-competent envelope glycoprotein complex.
Welman M; Lemay G; Cohen EA
Virus Res; 2007 Mar; 124(1-2):103-12. PubMed ID: 17129629
[TBL] [Abstract][Full Text] [Related]
12. Role of gp41 glycosylation sites in the biological activity of human immunodeficiency virus type 1 envelope glycoprotein.
Perrin C; Fenouillet E; Jones IM
Virology; 1998 Mar; 242(2):338-45. PubMed ID: 9514971
[TBL] [Abstract][Full Text] [Related]
13. Human immunodeficiency virus (HIV) gp41 escape mutants: cross-resistance to peptide inhibitors of HIV fusion and altered receptor activation of gp120.
Desmezieres E; Gupta N; Vassell R; He Y; Peden K; Sirota L; Yang Z; Wingfield P; Weiss CD
J Virol; 2005 Apr; 79(8):4774-81. PubMed ID: 15795263
[TBL] [Abstract][Full Text] [Related]
14. Differential effects of a hydrophobic tripeptide on human immunodeficiency virus type 1 (HIV-1)-induced syncytium formation and viral infectivity.
Konopka K; Pretzer E; Düzgünes N
Biochem Biophys Res Commun; 1995 Mar; 208(1):75-81. PubMed ID: 7887968
[TBL] [Abstract][Full Text] [Related]
15. An anti-human immunodeficiency virus multiple antigen peptide encompassing the cleavage region of the env precursor interferes with membrane fusion at a post-CD4 binding step.
Barbouche R; Decroly E; Kieny MP; Fenouillet E
Virology; 2000 Jul; 273(1):169-77. PubMed ID: 10891419
[TBL] [Abstract][Full Text] [Related]
16. Differential inhibition of HIV-1 and SIV envelope-mediated cell fusion by C34 peptides derived from the C-terminal heptad repeat of gp41 from diverse strains of HIV-1, HIV-2, and SIV.
Gustchina E; Hummer G; Bewley CA; Clore GM
J Med Chem; 2005 Apr; 48(8):3036-44. PubMed ID: 15828842
[TBL] [Abstract][Full Text] [Related]
17. A molecular model for membrane fusion based on solution studies of an amphiphilic peptide from HIV gp41.
Fujii G; Horvath S; Woodward S; Eiserling F; Eisenberg D
Protein Sci; 1992 Nov; 1(11):1454-64. PubMed ID: 1303764
[TBL] [Abstract][Full Text] [Related]
18. Natural variation in the amino acid sequence around the HIV type 1 glycoprotein 160 cleavage site and its effect on cleavability, subunit association, and membrane fusion.
Adams O; Schaal H; Scheid A
AIDS Res Hum Retroviruses; 2000 Sep; 16(13):1235-45. PubMed ID: 10957721
[TBL] [Abstract][Full Text] [Related]
19. The membrane-proximal fusion domain of HIV-1 GP41 reveals sequence-specific and fine-tuning mechanism of membrane binding.
Efremov RG; Volynsky PE; Nolde DE; Vergoten G; Arseniev AS
J Biomol Struct Dyn; 2007 Oct; 25(2):195-205. PubMed ID: 17718599
[TBL] [Abstract][Full Text] [Related]
20. The amino-terminal peptide of HIV-1 gp41 interacts with human serum albumin.
Gordon LM; Curtain CC; McCloyn V; Kirkpatrick A; Mobley PW; Waring AJ
AIDS Res Hum Retroviruses; 1993 Nov; 9(11):1145-56. PubMed ID: 8312056
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
